My Bibliography

select

Verboon LJ, Barwe SP, Tavenner M, Faust JR, Issa H, Gonçalves-Dias J, Schuschel K, Bhayadia R, van Berkel PH, Sebastian A, Ries RE, Paczesny S, Meshinchi S, Hitzler J, Pikman Y, Kolb EA, Heckl D, Klusmann JH, Gopalakrishnapillai A. DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia. Blood Adv. 2026 Jun 23;10(12):4120-4133. doi: 10.1182/bloodadvances.2025018830. PubMed PMID: 41945753; PubMed Central PMCID: PMC13263694.

select

Wang T, Ferreira AC, Hossain NM, Fu D, Hill EG, Jimenez Jimenez AM, Benjamin C, Komanduri KV, Paczesny S. Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation. Br J Haematol. 2026 Aug;209(2):653-659. doi: 10.1111/bjh.70507. Epub 2026 Apr 28. PubMed PMID: 42047487; PubMed Central PMCID: PMC13188006.

select

Paczesny S, Barwe SP, Gopalakrishnapillai A, Cheung NV. T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges. Cell Rep Med. 2026 May 19;7(5):102772. doi: 10.1016/j.xcrm.2026.102772. Epub 2026 Apr 27. Review. PubMed PMID: 42049030; PubMed Central PMCID: PMC13198315.

select

Martens MJ, Dutta D, Yu Y, Rein LE, Ritz J, Logan BR, Paczesny S. The BIOPREVENT machine-learning algorithm predicts chronic graft-versus-host disease and mortality risk using posttransplant biomarkers. J Clin Invest. 2026 Feb 16;136(4). doi: 10.1172/JCI195228. eCollection 2026 Feb 16. PubMed PMID: 41697751; PubMed Central PMCID: PMC12904722.

select

Markova A, Lee SJ, Modi B, Baumrin E, Rosenstein RK, Tkaczyk ER, Lehman JS, Inamoto Y, Carpenter PA, Schultz KR, Pidala JA, Martin P, Pusic I, Goklemez S, Stockmann C, Pinal-Fernandez I, Paczesny S, Harris A, Ponce DM, Holtzman NG, Jurdi NE, Pavletic SZ, Cowen EW. Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force. Transplant Cell Ther. 2026 Jun;32(6):644.e1-644.e19. doi: 10.1016/j.jtct.2026.01.009. Epub 2026 Jan 13. Review. PubMed PMID: 41539488; PubMed Central PMCID: PMC12858292.

select

Ferreira AC, Dutta D, Rowan CM, Renbarger J, Cooke KR, Carpenter PA, Krance R, Duncan C, Cruz CRY, Jacobsohn D, Bollard CM, Hill E, Paczesny S. Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13;10(1):168-180. doi: 10.1182/bloodadvances.2025016624. PubMed PMID: 40966416; PubMed Central PMCID: PMC12805280.

select

Saultz JN, Bolon YT, Wang T, Spellman SR, Lee SJ, He M, Camacho-Bydume C, Krishna C, Chowell D, Shaffer BC, Hsu KC, Paczesny S, Gadalla SM, Marsh SGE, Betts BC, Arrieta-Bolaños E. Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation. Transplant Cell Ther. 2026 Apr;32(4):434.e1-434.e11. doi: 10.1016/j.jtct.2025.12.949. Epub 2025 Dec 13. PubMed PMID: 41397550; PubMed Central PMCID: PMC13059967.

select

McCurdy SR, Solomon SR, Shaffer BC, He M, Bolon YT, Blouin AG, Keyzner A, Socola FA, Ibrahim U, Zou J, Safah H, Saba N, Gadalla S, Perales MA, Paczesny S, Marsh SGE, Petersdorf EW, Wang T, Lee SJ, Fuchs EJ. Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation. Transplant Cell Ther. 2026 Jan;32(1):74.e1-74.e14. doi: 10.1016/j.jtct.2025.09.048. Epub 2025 Oct 1. PubMed PMID: 41043776; PubMed Central PMCID: PMC12767214.

select

Gafken PR, Paczesny S. Blood proteomics for quantitative biomarkers of cellular therapies. Biomark Res. 2025 Sep 29;13(1):120. doi: 10.1186/s40364-025-00837-4. Review. PubMed PMID: 41024277; PubMed Central PMCID: PMC12481993.

select

Jiang H, Fu D, Pasupuleti SK, Ramdas B, Long A, Ramadan AM, Yang J, Kumar R, Hartman JH, Kendrick BJ, Simpson E, Gao H, Liu Y, Moore D, Subramanian S, Berto S, Gopalakrishnapillai A, Barwe SP, Guo H, Cheung NV, Kapur R, Paczesny S. ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche. Nat Commun. 2025 Jul 21;16(1):6580. doi: 10.1038/s41467-025-61647-8. PubMed PMID: 40691440; PubMed Central PMCID: PMC12279971.

select

Fu D, Jiang H, Long A, Harris E, Guo H, Capitano ML, Wrangle J, Faust JR, Gopalakrishnapillai A, Pasupuleti SK, Ramdas B, Kapur R, Barwe SP, Cheung NV, Paczesny S. Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway. Nat Commun. 2025 Jul 14;16(1):6369. doi: 10.1038/s41467-025-61567-7. PubMed PMID: 40659660; PubMed Central PMCID: PMC12259856.

select

Paczesny S, Hozo I, Djulbegovic B. Biomarker-derived fast-and-frugal decision tree for preemption of veno-occlusive disease/sinusoidal obstructive syndrome. Blood Adv. 2024 Oct 22;8(20):5426-5429. doi: 10.1182/bloodadvances.2024013670. PubMed PMID: 39207866; PubMed Central PMCID: PMC11526061.

select

Yuan X, Rech JC, Ramaraju A, Patil AD, Rajanayake K, Yuan H, Kazemi Sabzvar M, Mandal M, Cho EB, Wen B, Jiang J, Leo MD, Singh UP, Sun D, Yang CY. Studies of Structure-Activity Relationship of 2-(Pyrrolidin-1ylmethyl)-1H-pyrrole-Based ST2 Inhibitors and Their Inhibition of Mast Cells Activation. ACS Med Chem Lett. 2024 Nov 14;15(11):2053-2059. doi: 10.1021/acsmedchemlett.4c00459. eCollection 2024 Nov 14. PubMed PMID: 39563831; PubMed Central PMCID: PMC11571090.

select

Sonawane K, Borse KN, Jefferson M, Damgacioglu H, Carpenter MJ, Pearce JL, Ogretmen B, Paczesny S, O'Bryan JP, Obeid JS, Ford ME, Deshmukh AA. Developing Catchment Area Data Dashboards for Cancer Centers: A Stakeholder- engaged Approach. medRxiv. 2024 Jul 8;. doi: 10.1101/2024.07.05.24309999. PubMed PMID: 39040170; PubMed Central PMCID: PMC11261938.

select

Copsel SN, Garrido VT, Barreras H, Bader CS, Pfeiffer B, Mateo-Victoriano B, Wolf D, Gallardo M, Paczesny S, Komanduri KV, Benjamin CL, Villarino AV, Saluja AK, Levy RB. Minnelide suppresses GVHD and enhances survival while maintaining GVT responses. JCI Insight. 2024 Apr 11;9(9). doi: 10.1172/jci.insight.165936. PubMed PMID: 38602775; PubMed Central PMCID: PMC11141936.

select

Atomwise AIMS Program. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024 Apr 2;14(1):7526. doi: 10.1038/s41598-024-54655-z. PubMed PMID: 38565852; PubMed Central PMCID: PMC10987645.

select

Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K. Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight. Front Immunol. 2024;15:1350470. doi: 10.3389/fimmu.2024.1350470. eCollection 2024. PubMed PMID: 38629074; PubMed Central PMCID: PMC11019434.

select

Buxbaum NP, Socié G, Hill GR, MacDonald KPA, Tkachev V, Teshima T, Lee SJ, Ritz J, Sarantopoulos S, Luznik L, Zeng D, Paczesny S, Martin PJ, Pavletic SZ, Schultz KR, Blazar BR. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD. Blood Adv. 2023 Sep 12;7(17):4886-4902. doi: 10.1182/bloodadvances.2022007611. PubMed PMID: 36322878; PubMed Central PMCID: PMC10463203.

select

Yuan X, Jiang H, Fu D, Rech JC, Robida A, Rajanayake K, Yuan H, He M, Wen B, Sun D, Liu C, Chinnaswamy K, Stuckey JA, Paczesny S, Yang CY. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors. ACS Pharmacol Transl Sci. 2023 Sep 8;6(9):1275-1287. doi: 10.1021/acsptsci.3c00122. eCollection 2023 Sep 8. PubMed PMID: 37705593; PubMed Central PMCID: PMC10496145.

select

Logan BR, Fu D, Howard A, Fei M, Kou J, Little MR, Adom D, Mohamed FA, Blazar BR, Gafken PR, Paczesny S. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. J Clin Invest. 2023 Aug 1;133(15). doi: 10.1172/JCI168575. PubMed PMID: 37526081; PubMed Central PMCID: PMC10378149.

select

Ostrin EJ, Rider NL, Alousi AM, Irajizad E, Li L, Peng Q, Kim ST, Bashoura L, Arain MH, Noor LZ, Patel N, Mehta R, Popat UR, Hosing C, Jenq RR, Rondon G, Hanash SM, Paczesny S, Shpall EJ, Champlin RE, Dickey BF, Sheshadri A. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons. 2023 Jun 1;7(6):421-430. doi: 10.4049/immunohorizons.2300031. PubMed PMID: 37289498; PubMed Central PMCID: PMC10491477.

select

Pasupuleti SK, Ramdas B, Burns SS, Palam LR, Kanumuri R, Kumar R, Pandhiri TR, Dave UP, Yellapu NK, Zhou X, Zhang C, Sandusky GE, Yu Z, Honigberg MC, Bick AG, Griffin GK, Niroula A, Ebert BL, Paczesny S, Natarajan P, Kapur R. Obesity-induced inflammation exacerbates clonal hematopoiesis. J Clin Invest. 2023 Jun 1;133(11). doi: 10.1172/JCI163968. PubMed PMID: 37071471; PubMed Central PMCID: PMC10231999.

select

Han Y, Bidgoli A, DePriest BP, Méndez A, Bijangi-Vishehsaraei K, Perez-Albuerne ED, Krance RA, Renbarger J, Skiles JL, Choi SW, Liu H, Paczesny S. Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation. JCI Insight. 2023 May 22;8(10). doi: 10.1172/jci.insight.168221. PubMed PMID: 37071469; PubMed Central PMCID: PMC10322680.

select

Palam LR, Ramdas B, Pickerell K, Pasupuleti SK, Kanumuri R, Cesarano A, Szymanski M, Selman B, Dave UP, Sandusky G, Perna F, Paczesny S, Kapur R. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway. JCI Insight. 2023 May 8;8(9). doi: 10.1172/jci.insight.163864. PubMed PMID: 36976647; PubMed Central PMCID: PMC10243813.

select

Sluter MN, Li Q, Yasmen N, Chen Y, Li L, Hou R, Yu Y, Yang CY, Meibohm B, Jiang J. The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders. Exp Biol Med (Maywood). 2023 May;248(9):811-819. doi: 10.1177/15353702231179926. Epub 2023 Jul 29. Review. PubMed PMID: 37515545; PubMed Central PMCID: PMC10468642.

select

Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia. Transplant Cell Ther. 2023 Jul;29(7):452.e1-452.e11. doi: 10.1016/j.jtct.2023.03.027. Epub 2023 Mar 29. PubMed PMID: 36997024; PubMed Central PMCID: PMC10330307.

select

Sluter MN, Bhuniya R, Yuan X, Ramaraju A, Chen Y, Yu Y, Parmar KR, Temrikar ZH, Srivastava A, Meibohm B, Jiang J, Yang CY. Novel, Brain-Permeable, Cross-Species Benzothiazole Inhibitors of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Dampen Neuroinflammation In Vitro and In Vivo. ACS Pharmacol Transl Sci. 2023 Apr 14;6(4):587-599. doi: 10.1021/acsptsci.2c00241. eCollection 2023 Apr 14. PubMed PMID: 37082746; PubMed Central PMCID: PMC10111624.

select

Crivello P, Arrieta-Bolaños E, He M, Wang T, Fingerson S, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation. J Clin Oncol. 2023 May 1;41(13):2416-2427. doi: 10.1200/JCO.22.01229. Epub 2023 Jan 20. PubMed PMID: 36669145; PubMed Central PMCID: PMC10150892.

select

Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A. Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas. Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028. Epub 2022 Dec 25. PubMed PMID: 36577482; PubMed Central PMCID: PMC10316698.

select

Olson TS, Frost BF, Duke JL, Dribus M, Xie HM, Prudowsky ZD, Furutani E, Gudera J, Shah YB, Ferriola D, Dinou A, Pagkrati I, Kim S, Xu Y, He M, Zheng S, Nijim S, Lin P, Xu C, Nakano TA, Oved JH, Carreno BM, Bolon YT, Gadalla SM, Marsh SG, Paczesny S, Lee SJ, Monos DS, Shimamura A, Bertuch AA, Gragert L, Spellman SR, Babushok DV. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities. JCI Insight. 2022 Nov 22;7(22). doi: 10.1172/jci.insight.163040. PubMed PMID: 36219480; PubMed Central PMCID: PMC9746824.

select

Ramdas B, Lakshmi Reddy P, Mali RS, Pasupuleti SK, Zhang J, Kelley MR, Paczesny S, Zhang C, Kapur R. Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia. JCI Insight. 2022 Sep 8;7(17). doi: 10.1172/jci.insight.162016. PubMed PMID: 36073548; PubMed Central PMCID: PMC9536269.

select

Arrieta-Bolaños E, Crivello P, He M, Wang T, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K. A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation. Blood. 2022 Aug 11;140(6):659-663. doi: 10.1182/blood.2022015708. PubMed PMID: 35609150; PubMed Central PMCID: PMC9373015.

select

Yuan X, Jiang H, Fu D, Robida A, Rajanayake K, Yuan H, Wen B, Sun D, Watch BT, Chinnaswamy K, Stuckey JA, Paczesny S, Rech JC, Yang CY. Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease. Bioorg Med Chem. 2022 Oct 1;71:116942. doi: 10.1016/j.bmc.2022.116942. Epub 2022 Jul 22. PubMed PMID: 35930851; PubMed Central PMCID: PMC9451522.

select

Bidgoli A, DePriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease. Transplant Cell Ther. 2022 Oct;28(10):657-666. doi: 10.1016/j.jtct.2022.07.008. Epub 2022 Jul 11. Review. PubMed PMID: 35830932; PubMed Central PMCID: PMC9547856.

select

Fu Y, Pajulas A, Wang J, Zhou B, Cannon A, Cheung CCL, Zhang J, Zhou H, Fisher AJ, Omstead DT, Khan S, Han L, Renauld JC, Paczesny S, Gao H, Liu Y, Yang L, Tighe RM, Licona-Limón P, Flavell RA, Takatsuka S, Kitamura D, Sun J, Bilgicer B, Sears CR, Yang K, Kaplan MH. Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9. Nat Commun. 2022 Jul 1;13(1):3811. doi: 10.1038/s41467-022-31596-7. PubMed PMID: 35778404; PubMed Central PMCID: PMC9249769.

select

Pratta M, Paczesny S, Socie G, Barkey N, Liu H, Owens S, Arbushites MC, Schroeder MA, Howell MD. A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease. Br J Haematol. 2022 Aug;198(4):729-739. doi: 10.1111/bjh.18300. Epub 2022 Jun 11. PubMed PMID: 35689489; PubMed Central PMCID: PMC9540806.

select

DePriest BP, Li H, Bidgoli A, Onstad L, Couriel D, Lee SJ, Paczesny S. Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease. Blood Adv. 2022 May 24;6(10):2981-2986. doi: 10.1182/bloodadvances.2021005420. PubMed PMID: 35030629; PubMed Central PMCID: PMC9131917.

select

Bidgoli A, Paczesny S. HLA-DQ + CD4 help = graft-versus-tumor effect. Blood. 2022 May 19;139(20):2999-3000. doi: 10.1182/blood.2022016117. PubMed PMID: 35587871.

select

Rowan CM, Smith L, Sharron MP, Loftis L, Kudchadkar S, Duncan CN, Pike F, Carpenter PA, Jacobsohn D, Bollard CM, Cruz CRY, Malatpure A, Farag S, Renbarger J, Little MR, Gafken PR, Krance RA, Cooke KR, Paczesny S. A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation. Blood Adv. 2022 Mar 22;6(6):1866-1878. doi: 10.1182/bloodadvances.2021005770. PubMed PMID: 35139145; PubMed Central PMCID: PMC8941462.

select

Yuan X, Chinnaswamy K, Stuckey JA, Yang CY. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding. J Phys Chem B. 2022 Mar 31;126(12):2394-2406. doi: 10.1021/acs.jpcb.2c00341. Epub 2022 Mar 16. PubMed PMID: 35294837; PubMed Central PMCID: PMC9354565.

select

Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MM, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon YT, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide. Blood. 2022 Mar 10;139(10):1452-1468. doi: 10.1182/blood.2021013443. PubMed PMID: 34724567; PubMed Central PMCID: PMC8914182.

select

Fu Y, Wang J, Zhou B, Pajulas A, Gao H, Ramdas B, Koh B, Ulrich BJ, Yang S, Kapur R, Renauld JC, Paczesny S, Liu Y, Tighe RM, Licona-Limón P, Flavell RA, Takatsuka S, Kitamura D, Tepper RS, Sun J, Kaplan MH. An IL-9-pulmonary macrophage axis defines the allergic lung inflammatory environment. Sci Immunol. 2022 Feb 18;7(68):eabi9768. doi: 10.1126/sciimmunol.abi9768. Epub 2022 Feb 18. PubMed PMID: 35179949; PubMed Central PMCID: PMC8991419.

select

McCurdy SR, Radojcic V, Tsai HL, Vulic A, Thompson E, Ivcevic S, Kanakry CG, Powell JD, Lohman B, Adom D, Paczesny S, Cooke KR, Jones RJ, Varadhan R, Symons HJ, Luznik L. Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood. 2022 Jan 27;139(4):608-623. doi: 10.1182/blood.2021013054. PubMed PMID: 34657151; PubMed Central PMCID: PMC8796655.

select

Paczesny S. Graft-versus-host disease treatment beyond corticosteroids in newly diagnosed patients?. Lancet Haematol. 2022 Jan;9(1):e2-e3. doi: 10.1016/S2352-3026(21)00376-8. PubMed PMID: 34971578.

select

Zou J, Wang T, He M, Bolon YT, Gadalla SM, Marsh SGE, Kuxhausen M, Gale RP, Sharma A, Assal A, Prestidge T, Aljurf M, Cerny J, Paczesny S, Spellman SR, Lee SJ, Ciurea SO. Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. Transplant Cell Ther. 2022 Feb;28(2):107.e1-107.e8. doi: 10.1016/j.jtct.2021.11.001. Epub 2021 Nov 11. PubMed PMID: 34774819; PubMed Central PMCID: PMC8848305.

select

Cruz CRY, Bo N, Bakoyannis G, Wright KE, Chorvinsky EA, Powell A, Bollard CM, Jacobsohn D, Cooke KR, Duncan C, Krance RM, Carpenter PA, Rowan CM, Paczesny S. Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort. Bone Marrow Transplant. 2022 Feb;57(2):279-281. doi: 10.1038/s41409-021-01456-x. Epub 2021 Oct 28. PubMed PMID: 34711916; PubMed Central PMCID: PMC8821012.

select

Jiang H, Fu D, Bidgoli A, Paczesny S. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor. Front Immunol. 2021;12:761448. doi: 10.3389/fimmu.2021.761448. eCollection 2021. Review. PubMed PMID: 34675938; PubMed Central PMCID: PMC8525316.

select

DePriest BP, Vieira N, Bidgoli A, Paczesny S. An overview of multiplexed analyses of CAR T-cell therapies: insights and potential. Expert Rev Proteomics. 2021 Sep;18(9):767-780. doi: 10.1080/14789450.2021.1992276. Epub 2021 Oct 17. PubMed PMID: 34628995; PubMed Central PMCID: PMC8626704.

select

Rangarajan HG, Pereira MSF, Brazauskas R, St Martin A, Kussman A, Elmas E, Verneris MR, Gadalla SM, Marsh SGE, Paczesny S, Spellman SR, Lee SJ, Lee DA. Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation. Transplant Cell Ther. 2021 Nov;27(11):926.e1-926.e10. doi: 10.1016/j.jtct.2021.08.009. Epub 2021 Aug 15. PubMed PMID: 34407489; PubMed Central PMCID: PMC8574163.

select

DeFilipp Z, Couriel DR, Lazaryan A, Bhatt VR, Buxbaum NP, Alousi AM, Olivieri A, Pulanic D, Halter JP, Henderson LA, Zeiser R, Gooley TA, MacDonald KPA, Wolff D, Schultz KR, Paczesny S, Inamoto Y, Cutler CS, Kitko CL, Pidala JA, Lee SJ, Socie G, Sarantopoulos S, Pavletic SZ, Martin PJ, Blazar BR, Greinix HT. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report. Transplant Cell Ther. 2021 Sep;27(9):729-737. doi: 10.1016/j.jtct.2021.05.004. Epub 2021 Jun 11. PubMed PMID: 34147469; PubMed Central PMCID: PMC8944207.